New York State Common Retirement Fund Aclaris Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 48,400 shares of ACRS stock, worth $121,968. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,400
Previous 64,200
24.61%
Holding current value
$121,968
Previous $91,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ACRS
# of Institutions
104Shares Held
81.7MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN14.3MShares$35.9 Million24.79% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$22.4 Million2.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.52MShares$16.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.28MShares$13.3 Million0.02% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.61MShares$11.6 Million0.59% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $168M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...